Reducing Sepsis Deaths in Newborns Through Home Visitation and Active Case Detection: Is it Realistic?
- PMID: 28611101
- PMCID: PMC5487079
- DOI: 10.9745/GHSP-D-17-00201
Reducing Sepsis Deaths in Newborns Through Home Visitation and Active Case Detection: Is it Realistic?
Abstract
Severe bacterial infection remains one of the major causes of newborn deaths in low-income countries. A key challenge for reducing this burden is making definitive treatment more easily available. Active case detection through early postnatal home visits can work under trial conditions but is difficult to implement at scale under routine conditions. In many settings, making treatment available at peripheral-level primary health care facilities may be more feasible.
Comment on
-
Effect on Neonatal Mortality of Newborn Infection Management at Health Posts When Referral Is Not Possible: A Cluster-Randomized Trial in Rural Ethiopia.Glob Health Sci Pract. 2017 Jun 27;5(2):202-216. doi: 10.9745/GHSP-D-16-00312. Print 2017 Jun 27. Glob Health Sci Pract. 2017. PMID: 28611102 Free PMC article. Clinical Trial.
References
-
- Baqui AH, El-Arifeen S, Darmstadt GL, et al. ; Projahnmo Study Group. Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial. Lancet. 2008;371(9628):1936–1944. 10.1016/S0140-6736(08)60835-1. - DOI - PubMed
-
- World Health Organization (WHO); United Nations Children's Fund (UNICEF). Home Visits for the Newborn Child: A Strategy to Improve Survival. Geneva: WHO; 2009. http://www.who.int/maternal_child_adolescent/documents/who_fch_cah_09_02... Accessed May 24, 2017. - PubMed
-
- African Neonatal Sepsis Trial (AFRINEST) group; Tshefu A, Lokangaka A, Ngaima S, et al. . Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial. Lancet. 2015;385(9979):1767–1776. 10.1016/S0140-6736(14)62284-4. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources